KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jun 20, 2017
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Award
Stock Options (right to buy)
2017-06-09+30,000→ 30,000 totalExercise: $6.56From: 2018-06-09Exp: 2027-06-09→ Common Stock (30,000 underlying) - Award
Common Stock
2017-06-09+10,000→ 170,000 total
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 9, 2018, June 9, 2019 and June 9, 2020.
- [F2]Includes 26,665 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 9, 2018, June 9, 2019 and June 9, 2020.